Pharmaceutical Reports
Facing patent expirations, pricing pressures, and R&D productivity challenges, pharma companies are relying on market research and consulting services to identify growth opportunities, demonstrate value, and bring innovative therapies to market. This guide provides insights into the pharma consulting landscape.
CTLA-4 Inhibitors Market
CTLA-4 Inhibitors Market, By Product Type (Monoclonal Antibodies, Small Molecules, Others), By Indication (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Others), By Route of Administration (Intravenous, Subcutaneous, Oral, Others), By Mechanism of Action (Immune Checkpoint Inhibition, T-Cell Activation, Others), By End User (Hospitals, Clinics, Cancer Research Centers, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Bristol-Myers Squibb, Merck & Co., Roche, AstraZeneca, Pfizer, Novartis, Sanofi
Complicated Urinary Tract Infections Market
Complicated Urinary Tract Infections Market, By Infection Type (Complicated Pyelonephritis, Complicated Lower UTI, Catheter-associated UTI, Others (Urologic Procedure-associated UTI, Renal Transplant-associated UTI)), By Pathogen Type (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter spp., Proteus spp., Acinetobacter baumannii, Others (Enterococcus spp., Staphylococcus spp.)), By Drug Class (Aminoglycosides, Cephalosporins, Carbapenems, Fluoroquinolones, Others (Polymyxins, Tetracyclines)), By Route of Administration (Intravenous, Oral, Others (Intramuscular, Topical)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Clinics, Medical Stores)), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others (Long-term Care Facilities, Home Healthcare)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG
Complement 3 Glomerulopathy Market
Complement 3 Glomerulopathy Market, By Type (Membranoproliferative Glomerulonephritis (MPGN), Dense Deposit Disease (DDD), C3 Glomerulonephritis (C3GN), Others (including Atypical Hemolytic Uremic Syndrome)), By Treatment Type (Immunosuppressive Therapies, Plasma Therapies, Complement Inhibitors, Gene Therapies, Kidney Transplantation, Others (including symptomatic treatments)), By Route of Administration (Intravenous, Oral, Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others (including research institutes)), By Mechanism of Action (Complement C3 Inhibitors, Complement C5 Inhibitors, Complement Factor B Inhibitors, Others (including anti-inflammatory agents)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Alexion Pharmaceuticals, Chemocentryx, Omeros Corporation, Genentech, Novartis
Cervical Cancer Market
Cervical Cancer Market, By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others), By Cancer Type (Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma, Small Cell Carcinoma, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Cancer Research Centers, Home Care Settings, Ambulatory Surgical Centers), By Stage (Early Stage (Stage 0 and Stage I), Locally Advanced Stage (Stage II and Stage III), Advanced Stage (Stage IV)), By Diagnostic Test (Pap Smear, HPV Testing, Colposcopy, Biopsy, Imaging Tests, Blood Tests), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC
Complement Inhibitors (C3/C5) Market
Complement Inhibitors (C3/C5) Market, By Product Type (C3 Inhibitors, C5 Inhibitors, C5a Inhibitors, Others (C3a inhibitors, C5b inhibitors, etc.)), By Route of Administration (Intravenous, Subcutaneous, Oral, Others (Intravitreal, Intrathecal, etc.)), By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder (NMOSD), Age-related Macular Degeneration (AMD), Lupus Nephritis, Others (Glomerulonephritis, Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, etc.)), By Mechanism of Action (Terminal Complement Inhibitors, Upstream Complement Inhibitors, Lectin Pathway Inhibitors, Alternative Pathway Inhibitors, Others (Anaphylatoxin inhibitors, Convertase inhibitors, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,Online Pharmacies, Others (Specialty Pharmacies, Mail-order Pharmacies, etc.)), By End-User (Hospitals, Clinics, Homecare Settings, Others (Research Institutes, Academic Organizations, etc.)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Alexion Pharmaceuticals (AstraZeneca), Apellis Pharmaceuticals, Novartis AG
Patient Registry Software Market
Patient Registry Software Market, By Software Type (Integrated, Standalone), By Delivery Mode (On-premises, Web-based, Cloud-based, Hybrid, Others), By Database Type (Public, Private, Hybrid), By Functionality (Population Health Management, Patient Care Management, Health Information Exchange, Point-of-Care, Product Outcome Evaluation, Disease Reporting, Others), By Pricing Model (Subscription-based, Perpetual Licensing, Usage-based, Freemium), By End-User (Healthcare Providers, Government & Third-Party Administrators, Research Organizations, Pharmaceutical & Biotechnology Companies, Medical Device Companies, Insurance Payers), By Application (Chronic Disease Management, Rare Disease Management, Drug Safety Surveillance, Clinical Trial Recruitment and Management, Post-Marketing Surveillance, Outcome Research, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Quintiles IMS Holdings, Inc. (IQVIA), Optum, Inc., FIGmd, Inc., McKesson Corporation
Urinary Tract Infection Treatment Market
Urinary Tract Infection Treatment Market, By Drug Class (Quinolones, Penicillins, Cephalosporins, Aminoglycosides, Others (Fosfomycin, Nitrofurantoin, Trimethoprim-sulfamethoxazole)), By Route of Administration (Oral, Parenteral, Others (Topical, Intravesical)), By Infection Type (Complicated UTIs, Uncomplicated UTIs, Recurrent UTIs, Others (Catheter-associated UTIs, Nosocomial UTIs)), By Pathogen Type (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus, Proteus mirabilis, Others (Enterococcus faecalis, Pseudomonas aeruginosa) By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others (Nursing Homes, Long-term Care Facilities)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Clinics, Mail Order Pharmacies)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, Sanofi S.A, Cadila Healthcare, Mylan N.V.
Anti-retroviral Drug Market
Anti-retroviral Drug Market, By Drug Class (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integrase Inhibitors, Entry/Fusion Inhibitors, Others (CCR5 Antagonists, Boosting Agents)), By Drug Combination (Single-Tablet Regimens (STRs), Multi-Tablet Regimens (MTRs), Others (Monotherapies), By Route of Administration (Oral, Parenteral), By Dosage Form (Tablets, Capsules, Oral Solutions/Syrups, Injections, Others (Granules, Powders)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Agencies, Others (Mail Order Pharmacies)), By End-User (Hospitals, Clinics, Homecare Settings, Others (Research Institutes, Pharmaceutical Companies)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Gilead Sciences, Inc., ViiV Healthcare, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc
Local And Dental Anesthesia Drugs Market
Local and Dental Anesthesia Drugs Market, By Product Type (Injectable Formulations, Topical Formulations, Others (Spray, Gel, etc.)), By Drug Class (Aminoamide Compounds, Aminoester Compounds, Others (Combinations, etc.)), By Route of Administration (Infiltration, Nerve Block, Topical, Others (Intravenous, etc.)), By Application (Surgical Anesthesia, Therapeutic Anesthesia, Diagnostic Anesthesia, Others (Cosmetic procedures, etc.), By End-User (Hospitals, Ambulatory Surgical Centers, Dental Clinics, Others (Research Institutes, etc.)), By Distribution Channel (Direct Tenders, Retail Pharmacies, Online Pharmacies, Others (Hospital Pharmacies, etc.)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Novartis AG, Fresenius SE & Co. KGaA, Baxter International Inc., Hospira Inc.
Small Molecule Drug Discovery Market
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology Cardiovascular Diseases Infectious Diseases Metabolic Disorders Neurological Disorders Autoimmune Diseases Others), By Drug Type (Small Molecule Synthetic Drugs Small Molecule Biologics Small Molecule Vaccines Small Molecule Gene Therapies Peptides Oligonucleotides Others), By Target Class (G-protein-coupled Receptors (GPCRs) Kinases Proteases Ion Channels Nuclear Receptors Enzymes Others), By Molecule Type (Synthetic Compounds Natural Compounds Peptides Oligonucleotides Others), By Phase of Development (Preclinical Phase I Phase II Phase III Approved/Marketed Drugs), By Service Type (Lead Identification Services Lead Optimization Services Candidate Selection Services Bioavailability and Solubility Studies Others), By Technology (High-throughput Screening (HTS) Computer-aided Drug Design (CADD) Combinatorial Chemistry Bioinformatics Structural Biology Nanotechnology Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Novartis AG, Merck & Co., Inc., Roche Holding AG, Johnson & Johnson